11 Sep BioCity co-invests to help NuVision secure £1.4m investment
MediCity, Nottingham based regenerative medicine company has secured a £1.4m investment to fund clinical trials on its new cutting-edge treatment for dry eye disease. The funding for NuVision Biotherapies Ltd comes in part from the MEIF Proof of Concept & Early Stage Fund, which is managed...